Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications.

BACKGROUND Levels of hemostasis factors vary between and within individuals as a result of genetic and environmental factors and analytical variation of the assays. The current state of the art for defining analytical precision requirements for analytical testing is based on this between- and within-individual (biological) variation. However, information on biological variation in hemostasis variables is still limited.The aim of this study was to determine the biological variation of coagulation variables involved in thrombosis and bleeding to provide a recommendation for performance specifications and to assess whether hemostasis assays fulfill the recommendation. METHODS We performed a longitudinal study by repeated blood sampling (in total 13 times over a 1-year period) in 40 healthy individuals and measured prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, antithrombin, factor VIII, factor IX, von Willebrand factor (VWF), protein C, and protein S. We evaluated the effect of the biological variation on parameters of analytical variation and propose required performance specifications. RESULTS Biological variation was highly different for various hemostasis variables: the within-subject variation ranged from 2.6% (PT) to 25.6% [VWF collagen binding (CB) activity], the between-subject variation varied from 4.1% (PT) to 31.2% (VWF:ristocetin cofactor acitivity), and the assay variation from 1.3% (PT) to 12.9% (VWF:CB). CONCLUSIONS With the reagents and analyzers used in this study, most of the hemostasis tests variables fulfill the current quality criteria for diagnosis and monitoring of routine hemostasis assays.

[1]  F. Driessler,et al.  Evaluation of recombinant factor VIII Fc (Eloctate) activity by thromboelastometry in a multicenter phase 3 clinical trial and correlation with bleeding phenotype , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[2]  Sverre Sandberg,et al.  Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine , 2015, Clinical chemistry and laboratory medicine.

[3]  Sverre Sandberg,et al.  Defining analytical performance specifications 15 years after the Stockholm conference , 2015, Clinical chemistry and laboratory medicine.

[4]  Wei Wu,et al.  Biological and Analytical Variations of 16 Parameters Related to Coagulation Screening Tests and the Activity of Coagulation Factors , 2015, Seminars in Thrombosis & Hemostasis.

[5]  G. Lippi,et al.  Could light meal jeopardize laboratory coagulation tests? , 2014, Biochemia medica.

[6]  M. Serteser,et al.  Biological variations of ADAMTS13 and von Willebrand factor in human adults , 2014, Biochemia medica.

[7]  R. Walton.  Subject-based reference values: biological variation, individuality, and reference change values. , 2012, Veterinary clinical pathology.

[8]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[9]  A. Hofman,et al.  High von Willebrand Factor Levels Increase the Risk of Stroke: The Rotterdam Study , 2010, Stroke.

[10]  H. ten Cate,et al.  Biological variation in inflammatory and hemostatic markers , 2009, Journal of thrombosis and haemostasis : JTH.

[11]  G. Lippi,et al.  Circadian variation within hemostasis: an underrecognized link between biology and disease? , 2009, Seminars in thrombosis and hemostasis.

[12]  C. Ricós,et al.  Integration of data derived from biological variation into the quality management system. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[13]  N. Hamasaki,et al.  Analytical goals for coagulation tests based on biological variation , 2004, Clinical chemistry and laboratory medicine.

[14]  C. Kluft,et al.  The long‐term within‐ and between‐laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation , 2003, Journal of thrombosis and haemostasis : JTH.

[15]  H. V. van Houwelingen,et al.  Long-term analytical performance of hemostasis field methods as assessed by evaluation of the results of an external quality assessment program for antithrombin. , 2002, Clinical chemistry.

[16]  B. Woodhams,et al.  Stability of coagulation proteins in frozen plasma , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  C Ricós,et al.  Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.

[18]  C G Fraser,et al.  General strategies to set quality specifications for reliability performance characteristics. , 1999, Scandinavian journal of clinical and laboratory investigation.

[19]  J. Stengård,et al.  Intra- and Interindividual Variability of Hemostatic Factors and Traditional Cardiovascular Risk Factors in a Three-year Follow-up , 1998, Thrombosis and Haemostasis.

[20]  Jean-Claude Libeer,et al.  Proposals for Setting Generally Applicable Quality Goals Solely Based on Biology , 1997, Annals of clinical biochemistry.

[21]  C. Kluft,et al.  Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[22]  L. Chambless,et al.  ARIC Hemostasis Study-IV. Intraindividual Variability and Reliability of Hemostatic Factors , 1995, Thrombosis and Haemostasis.

[23]  A. Folsom,et al.  Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study. , 1992, Annals of epidemiology.

[24]  D. Dot,et al.  Within-Subject and Between-Subject Biological Variation of Prothrombin Time and Activated Partial Thromboplastin Time , 1992, Annals of clinical biochemistry.

[25]  Harris Ek.  Proposed goals for analytical precision and accuracy in single-point diagnostic testing. Theoretical basis and comparison with data from College of American Pathologists proficiency surveys. , 1988 .

[26]  S. Thompson,et al.  Sources of Variability in Coagulation Factor Assays , 1987, Thrombosis and Haemostasis.

[27]  P. Brombacher,et al.  Short-Term and Long-Term Intra-Individual Variations and Critical Differences of Coagulation Parameters , 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[28]  P. Cohen,et al.  Estimating biological variation in diagnostic tests. , 1982, Clinical chemistry.

[29]  J O Westgard,et al.  A multi-rule Shewhart chart for quality control in clinical chemistry. , 1981, Clinical chemistry.

[30]  E. K. Harris,et al.  Statistical principles underlying analytic goal-setting in clinical chemistry. , 1979, American journal of clinical pathology.

[31]  D S Young,et al.  Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designed to eliminate long-term analytic deviations. , 1970, Clinical chemistry.

[32]  G. Banfi,et al.  Biological Variation in Tests of Hemostasis , 2009, Seminars in thrombosis and hemostasis.

[33]  C G Fraser,et al.  Generation and application of data on biological variation in clinical chemistry. , 1989, Critical reviews in clinical laboratory sciences.

[34]  E. K. Harris.  Proposed goals for analytical precision and accuracy in single-point diagnostic testing. Theoretical basis and comparison with data from College of American Pathologists proficiency surveys. , 1988, Archives of pathology & laboratory medicine.

[35]  E. K. Harris,et al.  Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. , 1970, Clinical chemistry.